Galectin Therapeutics Inc
GALT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133416
In the last 90 days, Galectin Therapeutics Inc insiders filed 0 open-market purchases and 1 sale; 98 institutions reported holding it in 13F filings for Q2 2026, worth $72.2M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Galectin Therapeutics Inc changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 93 | 1 | 86 | −6 |
| Shares | 9.96M | 6.00K | 10.5M | +557.8K (+5.6%) |
| Value | $12.2M | $7.32K | $22.2M | +$10.0M (+82.3%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Galectin Therapeutics Inc at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 748,652 | $1.58M | 0.00% |
| Millennium Management LLC | 144,528 | $305.0K | 0.00% |
| Citadel Advisors LLC | 103,297 | $218.0K | 0.00% |
| HRT Financial LP | 77,200 | $162.0K | 0.00% |
| Truist Financial Corp | 68,000 | $143.5K | 0.00% |
| Group One Trading, L.P. | 66,196 | $139.7K | 0.00% |
| Marshall Wace, LLP | 30,400 | $64.1K | 0.00% |
| Summit Trail Advisors, LLC | 20,000 | $42.2K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 14,589 | $30.8K | 0.01% |
| Tang Capital Management LLC | 12,913 | $27.2K | 0.00% |
| Financial Gravity Companies, Inc. | 5,997 | $12.7K | 0.00% |
| Cubist Systematic Strategies, LLC | 561 | $1.18K | 0.00% |
| Global Retirement Partners, LLC | 250 | $528 | 0.00% |
| Point72 (DIFC) Ltd | 187 | $395 | 0.00% |
| Essential Partners LLC | 1 | $2 | 0.00% |
Sold out (21)
Institutions that held Galectin Therapeutics Inc at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Y-Intercept (Hong Kong) Ltd | 235,192 | $286.9K |
| Atria Wealth Solutions, Inc. | 186,000 | $226.9K |
| Gsa Capital Partners LLP | 66,396 | $81.0K |
| Bank of New York Mellon Corp | 50,826 | $62.0K |
| Nuveen, LLC | 27,623 | $33.7K |
| Charles Schwab Investment Management Inc | 22,913 | $28.0K |
| The PNC Financial Services Group, Inc. | 20,000 | $24.4K |
| Kovitz Investment Group Partners, LLC | 18,315 | $22.3K |
| Rhumbline Advisers | 16,401 | $20.0K |
| Lido Advisors, LLC | 15,300 | $18.7K |
| Intech Investment Management LLC | 14,156 | $17.3K |
| New York State Common Retirement Fund | 12,600 | $15.4K |
| Barclays PLC | 9,326 | $11.4K |
| Corebridge Financial, Inc. | 4,402 | $5.37K |
| Ameritas Investment Partners, Inc. | 1,995 | $2.43K |
| California State Teachers Retirement System | 1,476 | $1.80K |
| Amalgamated Bank | 705 | $1.00K |
| Sterling Capital Management LLC | 74 | $90 |
| Legal & General Group Plc | 38 | $46 |
| FNY Investment Advisers, LLC | 600 | $0 |
| Avion Wealth | 237 | $0 |
Not filed for Q2 2025 yet (1)
Institutions that held Galectin Therapeutics Inc at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Sofos Investments, Inc. | 5,997 | $7.32K |